Dr. David Klonoff, Medical Director of the Diabetes Research Institute (DRI)
Faster and more effective treatments for diabetes are on the horizon, and Mills-Peninsula’s Diabetes Research Institute (DRI) is leading the charge to get these new products and drugs to market.
Working with companies that manufacture products to treat diabetes, the DRI conducts clinical trials and aids the development process until the offerings are ready to be submitted to the Federal Drug Administration (FDA) for approval.
“We’ve helped test and develop many of the diabetes drugs and devices on the market today,” said David Klonoff, M.D., medical director of the DRI.
{ 0 comments }
